Education
About Us
Working with TipRanks
Follow Us
Jacobson Pharma Corporation Limited (HK:2633)
:2633
RESEARCH TOOLSreports
2633 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.56 - HK$1.42
Previous CloseN/A
Volume1.98M
Average Volume (3M)1.01M
Market Cap
HK$2.70B
Enterprise ValueHK$2.42B
Total Cash (Recent Filing)HK$563.79M
Total Debt (Recent Filing)HK$699.85M
Price to Earnings (P/E)9.4
Beta0.27
Next Earnings
Nov 21, 2025EPS EstimateN/A
Next Dividend Ex-Date
Aug 11, 2025Dividend Yield4.93%
Share Statistics
EPS (TTM)0.08
Shares Outstanding2,000,221,000
10 Day Avg. Volume853,699
30 Day Avg. Volume1,009,236
Financial Highlights & Ratios
PEG Ratio0.18
Price to Book (P/B)0.68
Price to Sales (P/S)0.00
P/FCF Ratio3.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Jacobson Pharma Corporation Limited News
PremiumCompany Announcements
Jacobson Pharma Reports Strong Financial Growth in 2025
PremiumCompany Announcements
Jacobson Pharma Announces Final Dividend for FY2025
PremiumCompany Announcements
Jacobson Pharma Announces Special Dividend for FY 2025
PremiumCompany Announcements
Jacobson Pharma Announces Director Retirement
PremiumCompany Announcements
Jacobson Pharma Schedules Board Meeting to Review Annual Results
PremiumCompany Announcements
Jacobson Pharma Projects Over 40% Profit Increase for FY2025PremiumCompany Announcements
Jacobson Pharma Expands Stake in Tycoon Group Amid Market Volatility
PremiumCompany Announcements
Jacobson Pharma to Acquire Significant Stake in Tycoon GroupOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.06%
Mutual Funds
― Other Institutional Investors
99.91% Public Companies and
Individual Investors
2633 FAQ
What was Jacobson Pharma Corporation Limited’s price range in the past 12 months?
Jacobson Pharma Corporation Limited lowest stock price was HK$0.56 and its highest was HK$1.42 in the past 12 months.
What is Jacobson Pharma Corporation Limited’s market cap?
Jacobson Pharma Corporation Limited’s market cap is HK$2.70B.
When is Jacobson Pharma Corporation Limited’s upcoming earnings report date?
Jacobson Pharma Corporation Limited’s upcoming earnings report date is Nov 21, 2025 which is in 158 days.
How were Jacobson Pharma Corporation Limited’s earnings last quarter?
Jacobson Pharma Corporation Limited released its earnings results on Jun 13, 2025. The company reported HK$0.08 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.08.
Is Jacobson Pharma Corporation Limited overvalued?
According to Wall Street analysts Jacobson Pharma Corporation Limited’s price is currently Overvalued.
Does Jacobson Pharma Corporation Limited pay dividends?
Jacobson Pharma Corporation Limited pays a Annually dividend of HK$0.064 which represents an annual dividend yield of 4.93%. See more information on Jacobson Pharma Corporation Limited dividends here
What is Jacobson Pharma Corporation Limited’s EPS estimate?
Jacobson Pharma Corporation Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jacobson Pharma Corporation Limited have?
Jacobson Pharma Corporation Limited has 2,000,221,000 shares outstanding.
What happened to Jacobson Pharma Corporation Limited’s price movement after its last earnings report?
Jacobson Pharma Corporation Limited reported an EPS of HK$0.08 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.65%.
Which hedge fund is a major shareholder of Jacobson Pharma Corporation Limited?
Currently, no hedge funds are holding shares in HK:2633
Jacobson Pharma Corporation Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
152.22%
12-Months-Change
Fundamentals
Return on Equity
12.47%
Trailing 12-Months
Asset Growth
4.54%
Trailing 12-Months
Company Description
Jacobson Pharma Corporation Limited
Jacobson Pharma Corporation Limited (2633) is a leading pharmaceutical company in Hong Kong, engaged in the research, development, production, and distribution of generic drugs and proprietary medicines. The company operates through two primary segments: generic drugs, which include a broad range of therapeutic products, and proprietary medicines, which encompass branded healthcare products. Jacobson Pharma has established a strong presence in the local pharmaceutical market and continues to expand its portfolio and distribution network to meet the diverse needs of patients and healthcare providers.
Technical Analysis
Sino Biopharmaceutical
―
Huarong International Financial Holdings Limited
―
Livzon Pharmaceutical Group
―
CSPC Pharmaceutical Group
―
China Medical System Holdings
―